Biocon Limited has submitted a regulatory filing to BSE Limited and the National Stock Exchange of India Limited intimating them of a scheduled meeting between company management and analysts/institutional investors.
The disclosure is made pursuant to Regulation 30(6) of the SEBI Listing Regulations.
Meeting Details
- Date: August 12, 2026
- Event: Emkay Confluence 2026
- Type of Interaction: Group meeting
- Venue: Virtual
The company included a note that this schedule is subject to change due to exigencies on the part of investors or the company.
Important Disclosure
Biocon explicitly stated that it will not disclose any Unpublished Price Sensitive Information (UPSI) during the analyst/investor meeting.
Additional Information
The company noted that this information will also be available on its website at www.biocon.com.
The document was signed by Rajesh Umakant Shanoy, Company Secretary and Compliance Officer (Membership No.: ACS 16328), on behalf of Biocon Limited.